The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cabot Oil & Gas Corporation (COG)

The Law Offices of Frank R. Cruz reminds investors of the upcoming October 13, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Cabot Oil & Gas Corporation (“Cabot Oil” or “the Company”) (NYSE: COG) securities between October 23, 2015 and June 12, 2020, inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

On July 26, 2019, the Company disclosed that it had received two proposed Consent Order and Agreements related to two Notices of Violation it had received from the Pennsylvania Department of Environmental Protection in 2017 for failure to prevent the migration of gas into fresh groundwater sources in the area surrounding Susquehanna County, Pennsylvania.

On this news, the Company’s share price fell $2.63, or over 12%, to close at $19.16 per share on July 26, 2019.

On June 15,

Read More

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Airbus SE (EADSY, EADSF)

The Law Offices of Frank R. Cruz reminds investors of the upcoming upcoming October 5, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Airbus SE (“Airbus” or the “Company”) (OTC: EADSY, EADSF) securities between February 24, 2016, and July 30, 2020, inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

On March 15, 2020, The Wall Street Journal reported that, according to internal documents related to the Company’s $4 billion bribery settlement, Airbus executives had previously raised red flags about fees paid to a number of middlemen working with its helicopter division, which was led at the time by the now-Chief Executive Officer, that may have violated global bribery and corruption rules.

On this news, Airbus ADRs fell $3.44 per share, or nearly 16%, to close at $18.46 per share on

Read More

ROSEN, A LEADING LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action

NEW YORK, Sept. 28, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of MEI Pharma, Inc. (NASDAQ: MEIP) between August 2, 2017 and July 1, 2020, inclusive (the “Class Period”), of the important October 9, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for MEI Pharma investors under the federal securities laws.

Rosen Law Firm, P.A. Logo
Rosen Law Firm, P.A. Logo

To join the MEI Pharma class action, go to http://www.rosenlegal.com/cases-register-1919.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) MEI Pharma overstated Pracinostat’s potential efficacy as an acute myeloid leukemia (“AML”), treatment for the target population; (2) consequently, the Phase 3 Pracinostat Trial was unlikely

Read More

ROSEN, A TOP RANKED LAW FIRM, Reminds Wrap Technologies, Inc. Investors of Important Deadline in Securities Class Action First Filed by the Firm

NEW YORK, Sept. 28, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Wrap Technologies, Inc. between July 31, 2020 and September 23, 2020, inclusive (the “Class Period”) of the important November 23, 2020 lead plaintiff deadline in the case commenced by the firm. The lawsuit seeks to recover damages for Wrap investors under the federal securities laws.

Rosen Law Firm, P.A. Logo
Rosen Law Firm, P.A. Logo

To join the Wrap class action, go to http://www.rosenlegal.com/cases-register-1953.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the Company had concealed the results of the LAPD BolaWrap pilot program, which demonstrated that the BolaWrap was ineffective, expensive, and sparingly used in the field; and (2)

Read More